<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2843">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04581096</url>
  </required_header>
  <id_info>
    <org_study_id>COVID19-MAPA</org_study_id>
    <nct_id>NCT04581096</nct_id>
  </id_info>
  <brief_title>Mapping COVID-19 Spread in a Tertiary Hospital</brief_title>
  <acronym>MEDyMAP</acronym>
  <official_title>Evaluation of the Response of COVID-19 Spread With a Spatiotemporal Analysis in a Tertiary Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario de Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Valencia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario de Valencia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      One of the major problems in suppressing the spreading of an epidemic resides in&#xD;
      understanding and monitoring its propagation patterns, and in evaluating how these are&#xD;
      modified by enforced policies. The standard solution requires detailed information at the&#xD;
      microscopic scales, e.g. how infected people have moved and whom they came in contact with,&#xD;
      which is hardly ever available. The researchers propose a novel approach to the study of the&#xD;
      propagation of COVID-19, in which a proxy of this information is derived at macroscopic&#xD;
      scales. This will be based on two ingredients: the spatiotemporal study in shiny with&#xD;
      mathematical models with aggregated or non aggregated data and the reconstruction of&#xD;
      functional networks of spreading patterns, and the development of a supporting software.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2, 2020</start_date>
  <completion_date type="Anticipated">June 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>spatiotemporal spread</measure>
    <time_frame>February 1, 2020 to September 30, 2020</time_frame>
    <description>spatiotemporal spread of COVID-19 patient in our hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>classification score</measure>
    <time_frame>February 1, 2020 to September 30, 2020</time_frame>
    <description>risk classification score of each patients with clinical and analytical variables</description>
  </secondary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Covid19</condition>
  <condition>Spatial Visualization</condition>
  <condition>Neural Network</condition>
  <condition>Respiratory Disease</condition>
  <condition>Pandemic</condition>
  <condition>Disease Spread</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>just descriptive analysis of clinical data</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a positive test (PCR or serology) for SARS-CoV-2 in an outpatient regime&#xD;
        system&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  positive test (PCR or serology) for SARS-CoV-2&#xD;
&#xD;
          -  outpatient follow-up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hospitalisation in ward or ICU&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHGUV</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolina S Romero Garcia, PhD</last_name>
      <phone>+3465454155</phone>
      <email>romero_carolinasol@gva.es</email>
    </contact>
    <contact_backup>
      <last_name>Adina Iftimi, PhD</last_name>
      <phone>+34635992819</phone>
      <email>adina.iftimi@uv.es</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>CHGUV</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolina Romero Garc√≠a, PhD</last_name>
      <phone>+34654541555</phone>
      <email>romero_carolinasol@gva.es</email>
    </contact>
    <contact_backup>
      <last_name>Adina Iftimi, PhD</last_name>
      <phone>+34635992819</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>October 8, 2020</last_update_submitted>
  <last_update_submitted_qc>October 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario de Valencia</investigator_affiliation>
    <investigator_full_name>Carolina Soledad Romero Garcia, MD, PhD</investigator_full_name>
    <investigator_title>Anesthesia and Critical care consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>there is not ipd sharing planned</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

